Buck Institute Launches AI-Powered Platform to Measure and Extend Healthspan
New Healthspan Horizons initiative combines real-world data with AI to identify what keeps people healthy longer.
Summary
The Buck Institute announced Healthspan Horizons, a groundbreaking research platform that uses AI to analyze real-world health data and identify factors that extend healthy lifespan. The initiative represents a major shift toward applying aging science practically. Additionally, the institute is participating in THRIVE, a Stanford-led coalition that secured $34.5M to develop the first FDA-grade score for measuring healthy aging.
Detailed Summary
The Buck Institute for Research on Aging has launched two major initiatives that could transform how we measure and extend healthy lifespan. The centerpiece is Healthspan Horizons, a new research infrastructure that combines real-world longitudinal health data with artificial intelligence to identify what keeps people healthy longer. According to Buck Institute CEO Eric Verdin, the science of aging has matured enough that extending healthy life is now within reach, but requires better infrastructure to organize and apply existing knowledge.
The institute is also participating in THRIVE (Transforming Health—Reclaiming Intrinsic Vitality for Everyone), a Stanford-led coalition that secured up to $34.5 million in ARPA-H funding. This initiative aims to develop the first FDA-grade "Intrinsic Capacity Score" to measure and predict healthy aging, potentially revolutionizing how clinicians assess age-related health risks.
Separately, Buck researchers discovered an unexpected connection between APOE4, a major Alzheimer's risk gene, and bone quality deficits in female mice. This finding suggests osteocytes (bone cells) could serve as early warning signals for both osteoporosis and Alzheimer's disease in midlife women.
These developments represent a significant shift from basic aging research toward practical applications that could directly impact patient care and public health strategies for extending healthspan.
Key Findings
- Healthspan Horizons platform uses AI to analyze real-world health data for healthspan extension
- THRIVE initiative secured $34.5M to develop first FDA-grade healthy aging measurement score
- APOE4 gene linked to bone quality deficits in female mice, suggesting early warning potential
- Osteocytes identified as potential biomarkers for both osteoporosis and Alzheimer's risk
Methodology
Healthspan Horizons combines longitudinal real-world health data with AI-driven discovery science. The APOE4 bone health study used female mouse models to examine connections between Alzheimer's risk genes and bone quality.
Study Limitations
Summary based on press release abstract only, without access to full research details. Clinical translation timelines and validation requirements for human applications remain unclear.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.